Patrick C. Gedeon

1.1k citations
31 papers · 808 · h-index 15

Impact in

  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Genetics top 5%
    • Glioma Diagnosis and Treatment
    • Virus-based gene therapy research

Papers in

    • CAR-T cell therapy research 16
    • Cancer Immunotherapy and Biomarkers 4
    • Immunotherapy and Immune Responses 8

Patrick C. Gedeon

28 papers receiving 794 citations

Peers

Patrick C. Gedeon
Comparison fields: 5 of 63
  • Oncology 495
  • Genetics 153
  • Immunology 273
  • Radiology, Nuclear Medicine and Imaging 118
  • Structural Biology 6
Replace Skyler P. Rietberg with:
Skyler P. Rietberg United States
Thomas Nerreter Germany
Vidyalakshmi Chandramohan United States
Vita S. Salsman United States
C A Kruse United States
Gerald E. Archer United States
Christopher R. Zito United States
Akane Yamamichi Japan
Katrin Töpfer Germany
Tina Verschuere Belgium
Patrick C. Gedeon relative to Skyler P. Rietberg United States Skyler P. Rietberg's profile →
Citations per field
00.5×20×40×60×78×
Skyler P. Rietberg · 1×
Citations per year

Countries citing papers authored by Patrick C. Gedeon

Since Specialization
Citations

This map shows the geographic impact of Patrick C. Gedeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Gedeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Gedeon more than expected).

Fields of papers citing papers by Patrick C. Gedeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Gedeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Gedeon. The network helps show where Patrick C. Gedeon may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick C. Gedeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick C. Gedeon Line = papers co-authored together Patrick C. Gedeon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012115
2 201394
3 201888
4 201364
5 201562
6 201854
7 201841
8 200936
9 201434
10 201432
11 201229
12 201328
13 202022
14 201322
15 201320
16 202013
17 20149
18 20238
19 20247
20 20235

About Patrick C. Gedeon

Patrick C. Gedeon is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 31 papers that have together received 808 indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (8 papers), Glioma Diagnosis and Treatment (6 papers), Protein Structure and Dynamics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Receptor Mechanisms and Signaling (4 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Oncology (495 citations), Genetics (153 citations), Immunology (273 citations), Radiology, Nuclear Medicine and Imaging (118 citations) and Structural Biology (6 citations). Patrick C. Gedeon has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, Darell D. Bigner, Carter M. Suryadevara, James E. Herndon, Gary E. Archer, Jeffry D. Madura, Duane A. Mitchell and Peter E. Fecci. Their work appears in journals such as OncoImmunology, Clinical Cancer Research, Proteins Structure Function and Bioinformatics, Expert Review of Clinical Pharmacology and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact